<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03281590</url>
  </required_header>
  <id_info>
    <org_study_id>17-281</org_study_id>
    <nct_id>NCT03281590</nct_id>
  </id_info>
  <brief_title>Stroke and Cerebrovascular Diseases Registry</brief_title>
  <official_title>Stroke and Cerebrovascular Diseases Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of New Mexico</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of New Mexico</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a single institutional registry database for the patients with stroke and&#xD;
      cerebrovascular diseases. Stroke is the fifth leading cause of death in the United States.&#xD;
      Despite extensive research, most of the patients die or suffer from varying degree of&#xD;
      post-stroke disabilities due to neurologic deficits. This registry aims to understand the&#xD;
      disease and examine the disease dynamics in the local community.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Stroke is the fifth cause of all-cause mortality in US http://www.cdc.gov/stroke/facts.htm&#xD;
      Early identification and treatment not only prevent mortality but also morbidity. Recent&#xD;
      advancement in the imaging and diagnostic technique and novel therapeutic modalities has&#xD;
      dramatically helped to downgrade stroke from the list of top mortality index in the last 3&#xD;
      years. However, studies determining factors which help predict stroke outcome are still&#xD;
      underway and much work needs to be done in this direction. Many factors currently are used to&#xD;
      predict stroke outcome with varying results, for e.g. NIHSS is a good predictor of stroke&#xD;
      outcome at 3 months; however, the investigators need better predictors, outcome scales or&#xD;
      outcome measures which are easy, reliable and has better specificity and sensitivity.&#xD;
&#xD;
      Acute Brain injury, Transient Ischemic Attack is a special category of a neurological&#xD;
      condition wherein there is an impending devastating outcome if workup is not completed in a&#xD;
      timely fashion. There is an urgent need to do investigations with high-risk patients to&#xD;
      prevent stroke and further mortality and morbidity. The abcd2 score can help us to risk&#xD;
      stratify the TIA and to predict the chances of stroke in this specific cohort. However,&#xD;
      investigators need better identifiers than already present, to improve the patient changes in&#xD;
      secondary prophylaxis of stroke prevention&#xD;
      http://www.stroke.org/sites/default/files/resources/tia-abcd2-tool.pdf?docID&#xD;
&#xD;
      There is also some correlation of clinical and biochemical predictors in subarachnoid,&#xD;
      cerebral venous thrombosis including Hunt and Hess, SAH score, WFNS-SAH grading among others&#xD;
      with variable predictive quality. (Rosen et al; Neurocritical Care; April 2005, Volume 2,&#xD;
      Issue 2, pp 110-118: Subarachnoid hemorrhage grading scales).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 6, 2017</start_date>
  <completion_date type="Anticipated">June 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Improvement or worsening in stroke signs/symptoms.</measure>
    <time_frame>1 year</time_frame>
    <description>Prospective and retrospective analysis of patients with the acute brain injury, transient ischemic attack, acute and chronic ischemic and hemorrhagic stroke, subarachnoid hemorrhage, and cerebral venous thrombosis from pre-hospitalization, hospitalization (in-patient) and post hospitalization (clinic) data to determine factors which can predict stroke outcome.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">10000</enrollment>
  <condition>Stroke</condition>
  <condition>Acute Stroke</condition>
  <condition>Acute Brain Injury</condition>
  <condition>Ischemic Stroke</condition>
  <condition>Hemorrhagic Stroke</condition>
  <condition>Transient Ischemic Attack</condition>
  <condition>Subarachnoid Hemorrhage</condition>
  <condition>Cerebral Ischemia</condition>
  <condition>Cerebral Infarction</condition>
  <condition>Cerebral Stroke</condition>
  <condition>Venous Sinus Thrombosis, Cranial</condition>
  <arm_group>
    <arm_group_label>Patients with stroke</arm_group_label>
    <description>Patients with the Acute Brain injury, Transient Ischemic Attack, Acute and Chronic Ischemic and Hemorrhagic Stroke, Subarachnoid hemorrhage, and cerebral venous thrombosis from pre-hospitalization, hospitalization (in-patient) and post hospitalization (clinic) data</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients without stroke</arm_group_label>
    <description>Control subject who have the risk factors but never had stroke.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with a final/discharge diagnosis of stroke or transient ischemic attack can be&#xD;
        included into the Stroke Registry. This includes cases with a principal/primary or&#xD;
        secondary diagnosis of:&#xD;
&#xD;
          -  Cerebral Infarction&#xD;
&#xD;
          -  Intracerebral Hemorrhage (non-traumatic)&#xD;
&#xD;
          -  Ischemic Stroke&#xD;
&#xD;
          -  Subarachnoid Hemorrhage (non-traumatic)&#xD;
&#xD;
          -  Transient Ischemic Attack (TIA)&#xD;
&#xD;
          -  Acute Brain Injury&#xD;
&#xD;
          -  Cerebral Venous Sinus Thrombosis&#xD;
&#xD;
        The investigators will use the available EMR and databases to search for these patients&#xD;
        using relevant ICD-9/10 codes.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. All patients with a diagnosis of Acute Brain injury, Transient Ischemic Attack, Acute&#xD;
             and Chronic Ischemic and Hemorrhagic Stroke, Subarachnoid hemorrhage, and cerebral&#xD;
             venous thrombosis seen in UNMH.&#xD;
&#xD;
          2. Age &gt;1 years of age.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patients who don't have the diagnosis of Acute Brain injury, Transient Ischemic&#xD;
             Attack, Acute and Chronic Ischemic and Hemorrhagic Stroke, Subarachnoid hemorrhage,&#xD;
             and cerebral venous thrombosis.&#xD;
&#xD;
          2. Patients who have Epidural Hematoma, Subdural hematoma.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michel Torbey, MD, MPH</last_name>
    <role>Study Chair</role>
    <affiliation>University of New Mexico</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Atif Zafar, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of New Mexico</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Asad Ikram, MD</last_name>
    <role>Study Director</role>
    <affiliation>University of New Mexico</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mudassir Farooqui, MD, MPH</last_name>
    <role>Study Director</role>
    <affiliation>University of New Mexico</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Atif Zafar, MD</last_name>
    <phone>5052724015</phone>
    <email>azafar@salud.unm.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Asad Ikram, MD</last_name>
    <phone>5052729382</phone>
    <email>aikram@salud.unm.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Neurology, University of New Mexico</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87131-0007</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ikram</last_name>
      <phone>505-272-9382</phone>
    </contact>
    <investigator>
      <last_name>Atif Zafar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Asad Ikram, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dinesh Jillella, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mudassir Farooqui, MD, MPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 11, 2017</study_first_submitted>
  <study_first_submitted_qc>September 11, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 13, 2017</study_first_posted>
  <last_update_submitted>October 12, 2021</last_update_submitted>
  <last_update_submitted_qc>October 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>identification</keyword>
  <keyword>diagnosis</keyword>
  <keyword>management</keyword>
  <keyword>investigation</keyword>
  <keyword>prevalence</keyword>
  <keyword>incidence</keyword>
  <keyword>quality of care</keyword>
  <keyword>hospitalization</keyword>
  <keyword>morbidity</keyword>
  <keyword>disability</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Brain Injuries</mesh_term>
    <mesh_term>Ischemic Stroke</mesh_term>
    <mesh_term>Subarachnoid Hemorrhage</mesh_term>
    <mesh_term>Ischemic Attack, Transient</mesh_term>
    <mesh_term>Cerebral Infarction</mesh_term>
    <mesh_term>Brain Ischemia</mesh_term>
    <mesh_term>Cerebrovascular Disorders</mesh_term>
    <mesh_term>Hemorrhagic Stroke</mesh_term>
    <mesh_term>Sinus Thrombosis, Intracranial</mesh_term>
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

